Stock listing
NASDAQ:CAMP CAMP4 Therapeutics Corporation Stock
Home listing (NASDAQ) of CAMP4 Therapeutics Corporation
Follow CAMP4 Therapeutics Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:CAMP
$3.78 USD -0.19 (-4.7%)
Close on Nov 2, 2026
- Day range
- $3.71 – $4.10 USDNov 2, 2026
- Volume
- 171,220 sharesNov 2, 2026
- Market cap
- $236.9M USDAt the close on Nov 2, 2026 · price × 62.75M shares outstanding
- 52-week range
- $2.90 – $7.75 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.09M USDMedian day 170,700 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CAMP · Home | $3.775 USD | -0.185 (-4.7%) | 171,220 | $4.02 | $4.10 | $3.71 | $3.96 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CAMP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.775 | -0.185 | -4.7% | $4.02 | $4.10 | $3.71 | 171,220 | |
| $3.96 | +0.06 | +1.5% | $3.86 | $4.00 | $3.775 | 137,649 | |
| $3.90 | +0.25 | +6.8% | $3.69 | $3.99 | $3.66 | 152,000 | |
| $3.65 | 0.00 | 0.0% | $3.65 | $3.66 | $3.48 | 99,100 | |
| $3.65 | +0.44 | +13.7% | $3.26 | $3.755 | $3.25 | 259,800 | |
| $3.21 | -0.09 | -2.7% | $3.32 | $3.32 | $3.19 | 60,100 | |
| $3.30 | -0.09 | -2.7% | $3.39 | $3.39 | $3.21 | 283,800 | |
| $3.39 | +0.10 | +3.0% | $3.20 | $3.50 | $3.195 | 141,100 | |
| $3.29 | +0.13 | +4.1% | $3.17 | $3.33 | $2.96 | 186,400 | |
| $3.16 | +0.02 | +0.6% | $3.18 | $3.38 | $3.11 | 89,200 | |
| $3.14 | -0.03 | -0.9% | $3.20 | $3.41 | $3.11 | 57,700 | |
| $3.17 | -0.28 | -8.1% | $3.45 | $3.45 | $3.17 | 92,400 | |
| $3.45 | +0.02 | +0.6% | $3.46 | $3.54 | $3.43 | 56,300 | |
| $3.43 | 0.00 | 0.0% | $3.33 | $3.445 | $3.17 | 155,700 | |
| $3.43 | -0.23 | -6.3% | $3.66 | $3.80 | $3.38 | 88,500 | |
| $3.66 | -0.11 | -2.9% | $3.71 | $3.76 | $3.65 | 36,100 | |
| $3.77 | +0.07 | +1.9% | $3.70 | $3.87 | $3.62 | 72,100 | |
| $3.70 | -0.14 | -3.6% | $3.80 | $3.80 | $3.51 | 278,300 | |
| $3.84 | -0.12 | -3.0% | $3.85 | $4.12 | $3.84 | 148,500 | |
| $3.96 | -0.05 | -1.2% | $4.03 | $4.03 | $3.75 | 1,230,500 | |
| $4.01 | +0.01 | +0.2% | $4.00 | $4.09 | $3.74 | 381,200 | |
| $4.00 | +0.16 | +4.2% | $3.90 | $4.05 | $3.69 | 368,000 | |
| $3.84 | -0.20 | -5.0% | $3.99 | $4.152 | $3.76 | 994,700 | |
| $4.04 | +0.13 | +3.3% | $3.96 | $4.09 | $3.86 | 170,700 | |
| $3.91 | +0.06 | +1.6% | $3.87 | $4.02 | $3.81 | 172,500 | |
| $3.85 | -0.07 | -1.8% | $3.86 | $3.95 | $3.73 | 116,900 | |
| $3.92 | +0.08 | +2.1% | $3.83 | $4.06 | $3.724 | 476,900 | |
| $3.84 | +0.12 | +3.2% | $3.78 | $3.94 | $3.675 | 130,300 | |
| $3.72 | -0.43 | -10.4% | $4.13 | $4.27 | $3.65 | 192,700 | |
| $4.15 | -0.02 | -0.5% | $4.21 | $4.24 | $3.86 | 161,200 | |
| $4.17 | -0.07 | -1.7% | $4.27 | $4.32 | $4.10 | 289,500 | |
| $4.24 | +0.21 | +5.2% | $4.03 | $4.27 | $3.945 | 1,043,100 | |
| $4.03 | +0.17 | +4.4% | $3.96 | $4.25 | $3.93 | 93,400 | |
| $3.86 | -0.33 | -7.9% | $4.19 | $4.37 | $3.84 | 300,800 | |
| $4.19 | -0.06 | -1.4% | $4.23 | $4.275 | $4.03 | 175,300 | |
| $4.25 | 0.00 | 0.0% | $4.26 | $4.49 | $4.18 | 167,000 | |
| $4.25 | -0.09 | -2.1% | $4.46 | $4.54 | $4.21 | 101,100 | |
| $4.34 | +0.01 | +0.2% | $4.30 | $4.495 | $4.145 | 115,600 | |
| $4.33 | -0.07 | -1.6% | $4.45 | $4.50 | $4.33 | 79,900 | |
| $4.40 | -0.01 | -0.2% | $4.40 | $4.53 | $4.30 | 280,500 | |
| $4.41 | -0.08 | -1.8% | $4.45 | $4.64 | $4.331 | 131,000 | |
| $4.49 | +0.69 | +18.2% | $3.87 | $4.53 | $3.76 | 1,280,500 | |
| $3.80 | +0.01 | +0.3% | $3.85 | $4.07 | $3.78 | 215,200 | |
| $3.79 | -0.17 | -4.3% | $3.85 | $3.95 | $3.70 | 229,400 | |
| $3.96 | -0.19 | -4.6% | $4.18 | $4.18 | $3.87 | 190,300 | |
| $4.15 | +0.01 | +0.2% | $4.18 | $4.30 | $4.03 | 142,100 | |
| $4.14 | -0.06 | -1.4% | $4.23 | $4.41 | $4.01 | 749,100 | |
| $4.20 | -0.25 | -5.6% | $4.45 | $4.528 | $4.05 | 364,500 | |
| $4.45 | +0.13 | +3.0% | $4.40 | $4.60 | $4.33 | 184,477 | |
| $4.32 | -0.16 | -3.6% | $4.46 | $4.517 | $4.26 | 109,480 | |
| $4.48 | +0.02 | +0.4% | $4.50 | $4.541 | $4.42 | 126,700 | |
| $4.46 | -0.19 | -4.1% | $4.57 | $4.95 | $4.37 | 395,700 | |
| $4.65 | -0.25 | -5.1% | $4.97 | $5.035 | $4.58 | 228,500 | |
| $4.90 | -0.10 | -2.0% | $5.00 | $5.178 | $4.84 | 128,500 | |
| $5.00 | -0.44 | -8.1% | $5.76 | $6.00 | $4.78 | 563,100 | |
| $5.44 | +0.94 | +20.9% | $4.50 | $5.48 | $4.21 | 426,600 | |
| $4.50 | -0.03 | -0.7% | $4.48 | $4.575 | $4.42 | 53,800 | |
| $4.53 | +0.36 | +8.6% | $4.20 | $4.63 | $4.12 | 493,100 | |
| $4.17 | -0.05 | -1.2% | $4.23 | $4.33 | $4.135 | 62,400 | |
| $4.22 | -0.02 | -0.5% | $4.25 | $4.29 | $4.09 | 85,300 | |
| $4.24 | -0.26 | -5.8% | $4.58 | $4.60 | $4.15 | 95,200 | |
| $4.50 | +0.49 | +12.2% | $4.20 | $4.585 | $4.04 | 658,800 | |
| $4.01 | -0.15 | -3.6% | $4.16 | $4.248 | $3.99 | 86,100 | |
| $4.16 | -0.05 | -1.2% | $4.28 | $4.36 | $4.06 | 210,500 | |
| $4.21 | +0.76 | +22.0% | $3.45 | $4.34 | $3.43 | 296,000 |
- Ticker
- NASDAQ:CAMP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union
Latest deck · Sep 28, 2026
Investor Day (September 2026)
Investor day · 30 slides
Calls
Replays
CAMP4 Therapeutics (NASDAQ:CAMP) Q3 2024 Earnings Call
Tue, Jan 09, 2024 · 5:00 PM ET
Watch TranscriptCAMP4 Therapeutics (NASDAQ:CAMP) Q2 2024 Earnings Call
Thu, Oct 05, 2023 · 5:00 PM ET
Watch TranscriptCAMP4 Therapeutics (NASDAQ:CAMP) Q1 2024 Earnings Call
Mon, Jul 10, 2023 · 5:00 PM ET
Watch Transcript
Latest news
CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union
Oct 27, 2026
Closed $3.65 (+13.7%) on Oct 27, 2026
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
Sep 10, 2026
Closed $4.34 (+0.2%) on Sep 10, 2026
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
Sep 8, 2026
Closed $4.33 (-1.6%) on Sep 9, 2026
CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug 13, 2026
Closed $5.44 (+20.9%) on Aug 14, 2026
CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug 13, 2026
Closed $5.44 (+20.9%) on Aug 14, 2026
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
Aug 4, 2026
Closed $4.16 (-1.2%) on Aug 4, 2026
CalAmp Expands Remote Monitoring Support for Modbus-Enabled Specialty Equipment
Jul 16, 2026
Closed $3.90 (-7.4%) on Jul 16, 2026
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
May 14, 2026
Closed $4.38 (-2.7%) on May 14, 2026
CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
May 7, 2026
Closed $4.46 (+2.8%) on May 8, 2026
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
Apr 28, 2026
Closed $4.27 (-3.8%) on Apr 28, 2026
Financings
Private placement of private placement securities
Aug 13, 2026
Closed: US$50.1M in the latest tranche · US$1.53 a share · Leerink Partners +3
Dealers: Leerink Partners (lead), Piper Sandler & Co., Cantor Fitzgerald & Co., Wedbush Securities Inc.
Buyers: Coastlands Capital; Janus Henderson Investors; Balyasny Asset Management; Vivo Capital; 5AM Ventures; Adage Capital Management LP; Trails Edge Capital Partners; CURE SYNGAP1
Insiders: 39,306 shares of common stock priced at $1.65 sold to certain directors, employees and consultants of the Company
Use of proceeds: Advance CMP-002 for SYNGAP1-related disorder, including a Phase 1/2 trial, and develop the early-stage pipeline
Update Jul 27, 2026 · Closed Aug 4, 2026 · Closed Aug 13, 2026
Decks
Investor Day (September 2026)
Investor day · 30 slides · Sep 28, 2026
Investor Presentation (September 2026)
Investor deck · 26 slides · Sep 28, 2026
Investor Presentation (May 2026)
Investor deck · 21 slides · May 14, 2026
Investor Presentation (March 2026)
Investor deck · 22 slides · Mar 5, 2026
CAMP4 Therapeutics Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 31 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 14 calls with a replay · 14 with a transcript · latest Jan 9, 2024
- Decks
- 8 decks · latest Sep 28, 2026
Where CAMP4 Therapeutics Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CAMP · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CAMP | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about CAMP4 Therapeutics Corporation.